Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2069 of 6351
-
New drug combo shows promise for rare thymic cancer
Disease control OngoingThis phase II trial studies how well pembrolizumab and sunitinib malate work in treating participants with thymic cancer that has spread to other places in the body or cannot be removed by surgery and does not respond to treatment. Monoclonal antibodies, such as pembrolizumab, ma…
Phase 2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can new tests unlock hidden cognitive changes in down syndrome?
Knowledge-focused CompletedAs basic and behavioral science identify new ways to improve cognition and behavior in individuals with Down syndrome (DS), the lack of rigorous outcome measures represents an important problem for interpreting findings. Null findings in clinical trials could result from insensit…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a registry make endoscopic procedures safer and more effective?
Knowledge-focused Recruiting nowAdvanced therapeutic endoscopy procedures are of increasing importance to provide minimal invasive treatment for GI diseases. The Centre Hospitalier de l'Université de Montréal as tertiary university center is dedicated to increase the availability of therapeutic endoscopy proced…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can we sustain a lifeline for new moms? study tests how to keep depression prevention alive
Prevention CompletedPostpartum depression (PPD) is common and can have lasting consequences for mother and child. ROSE is an intervention to prevent PPD, delivered during pregnancy in outpatient prenatal settings. ROSE has been found to significantly reduce cases of PPD in multiple randomized trials…
Sponsor: Michigan State University • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Could a patch behind the ear silence tinnitus?
Symptom relief CompletedThis study tested whether a skin patch, worn behind the ear, could help reduce tinnitus (ringing or buzzing in the ears) in adults. Eighty participants took part. Half wore an active patch, and half wore a patch that looked the same but had no active effect (a placebo). Neither t…
Sponsor: Murat Erinç • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Immunotherapy plus precision radiation shows promise for rare skin cancer
Disease control CompletedThis randomized phase II trial studies how well pembrolizumab with or without stereotactic body radiation therapy works in treating patients with Merkel cell cancer that has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembroliz…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Watching the brain and body during OCD triggers: a window into the disorder
Knowledge-focused OngoingThe investigators propose to synchronize automated measurements of behavior - head, body, and face dynamics, gaze, and vocal prosody - with simultaneous recordings of brain activity in clinically relevant contexts.
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Common painkiller tested against rare brain tumors
Disease control OngoingThis is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.
Phase 2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Liver-targeted chemo shows promise for tough bile duct cancer
Disease control Recruiting nowWe hypothesized that intra-arterial gemcitabine/oxaliplatin administered as second-line treatment could strongly improve objective response rate at 4 months after inclusion in patient with non-metastatic unresectable intra-hepatic cholangiocarcinoma.
Phase 2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advanced solid tumors or lymphoma that have progressed or are non responsive to available therapies and for which no standard…
Phase 1/2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental CAR-T therapy takes on tough lymphomas
Disease control CompletedThis is an open-label, multicenter, dose-escalation phase 1 study to determine the safety and efficacy of BZ019 in relapsed or refractory CD19+ B-cell Lymphoma.
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Sound waves vs. breast cancer: no scalpel needed?
Disease control Recruiting nowMonocentric prospective study evaluating the efficacy of High intensity focused ultrasound (HIFU) in breast tumors.
Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New heart valve device offers hope for patients with congenital defects
Disease control OngoingThis study will assess the safety and performance of the GORE PV1 Device for replacement of the pulmonary valve and reconstruction of the Right Ventricular Outflow Tract (RVOT).
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Custom vaccine shows promise in targeting aggressive breast cancer
Disease control CompletedThe purpose of this study is to learn more about how to treat patients with HER-2/neu positive invasive breast cancer (IBC). HER-2/neu is a type of protein that is known to be over-expressed in aggressive breast cancer. The study drug for this trial is DC1 study vaccine which is…
Early phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Sickle cell drug voxelotor tested for Long-Term safety
Disease control Stopped earlyOpen Label Extension Study of Voxelotor Clinical Trial Participants with Sickle Cell Disease Who Participated in Voxelotor Clinical Trials
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental antibody shows promise for rare amyloid disease
Disease control CompletedThis phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclonal antibodies, such as isatuximab, may interfere with the ability of cancer cells to grow and spread.
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
Experimental drug ruxolitinib joins standard therapy in brain cancer battle
Disease control CompletedThe purpose of this study is to test how well the drug works, safety and tolerability of an investigational drug called Ruxolitinib in gliomas and glioblastomas, when combined with standard treatment for brain cancer, temozolomide and radiation. Ruxolitinib is an experimental dr…
Phase 1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Blood pressure and eye tests may guide PTSD treatment
Symptom relief OngoingPost-traumatic stress disorder (PTSD) affects many individuals who experience a traumatic event. There are a variety of treatment options for PTSD, including psychotherapy (talk therapy) options, as well as medications, such as the drug prazosin. Each of the treatment options ava…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Artery-Saving surgery may reduce complications after esophageal cancer removal
Disease control CompletedThis randomized controlled trial evaluates the impact of preserving versus ligating the Right Gastric Artery (RGA) on postoperative anastomotic complications in patients undergoing McKeown minimally invasive esophagectomy (MIE) for esophageal squamous cell carcinoma. Specifically…
Sponsor: The First Hospital of Hebei Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Which tendon best fixes a slipping kneecap? a surgical showdown
Disease control CompletedThis prospective comparative study compared the clinical and radiological outcomes of medial patellofemoral ligament (MPFL) reconstruction using a hamstring tendon graft versus a quadriceps tendon graft in patients with recurrent patellar dislocation. The study included 38 patien…
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC